Your browser doesn't support javascript.
High Incidence Rate of SARS-CoV-2 Infection in Health Care Workers at a Dedicated COVID-19 Hospital: Experiences of the Pandemic from a Large Mexican Hospital.
Bueno-Hernández, Nallely; Carrillo-Ruíz, José Damian; Méndez-García, Lucía A; Rizo-Téllez, Salma A; Viurcos-Sanabria, Rebeca; Santoyo-Chávez, Alisson; Márquez-Franco, René; Aguado-García, Alejandro; Baltazar-López, Neyla; Tomita-Cruz, Yoshio; Barrón, Eira Valeria; Sánchez, Ana Laura; Márquez, Edna; Fossion, Ruben; Rivera, Ana Leonor; Ruelas, Luis; Lecona, Octavio A; Martínez-Mekler, Gustavo; Müller, Markus; Arroyo-Valerio, América G; Escobedo, Galileo.
  • Bueno-Hernández N; Laboratory of Proteomics, Research Division, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06726, Mexico.
  • Carrillo-Ruíz JD; Research Directorate, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06726, Mexico.
  • Méndez-García LA; Department of Neurology and Neurosurgery, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06726, Mexico.
  • Rizo-Téllez SA; Facultad de Ciencias de la Salud, Universidad Anáhuac, Huixquilucan 52786, Mexico.
  • Viurcos-Sanabria R; Laboratory of Immunometabolism, Research Division, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06726, Mexico.
  • Santoyo-Chávez A; Laboratory of Immunometabolism, Research Division, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06726, Mexico.
  • Márquez-Franco R; Laboratory of Immunometabolism, Research Division, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06726, Mexico.
  • Aguado-García A; Laboratory of Proteomics, Research Division, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06726, Mexico.
  • Baltazar-López N; Research Directorate, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06726, Mexico.
  • Tomita-Cruz Y; Research Directorate, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06726, Mexico.
  • Barrón EV; Research Directorate, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06726, Mexico.
  • Sánchez AL; Research Directorate, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06726, Mexico.
  • Márquez E; Unidad de Medicina Genómica, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06726, Mexico.
  • Fossion R; Unidad de Medicina Genómica, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06726, Mexico.
  • Rivera AL; Unidad de Medicina Genómica, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06726, Mexico.
  • Ruelas L; Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
  • Lecona OA; Centro de Ciencias de la Complejidad (C3), Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
  • Martínez-Mekler G; Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
  • Müller M; Centro de Ciencias de la Complejidad (C3), Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
  • Arroyo-Valerio AG; Centro de Ciencias de la Complejidad (C3), Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
  • Escobedo G; Centro de Ciencias de la Complejidad (C3), Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
Healthcare (Basel) ; 10(5)2022 May 12.
Article in English | MEDLINE | ID: covidwho-1855571
ABSTRACT
Health care workers (HCW) are at high risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The incidence of SARS-CoV-2 infection in HCW has been examined in cross-sectional studies by quantitative polymerase chain reaction (qPCR) tests, which may lead to underestimating exact incidence rates. We thus investigated the incidence of SARS-CoV-2 infection in a group of HCW at a dedicated coronavirus disease 2019 (COVID-19) hospital in a six-month follow-up period. We conducted a prospective cohort study on 109 participants of both sexes working in areas of high, moderate, and low SARS-CoV-2 exposure. qPCR tests in nasopharyngeal swabs and anti-SARS-CoV-2 IgG serum antibodies were assessed at the beginning and six months later. Demographic, clinical, and laboratory parameters were analyzed according to IgG seropositivity by paired Student's T-test or the chi-square test. The incidence rate of SARS-CoV-2 infection was considerably high in our cohort of HCW (58%), among whom 67% were asymptomatic carriers. No baseline risk factors contributed to the infection rate, including the workplace. It is still necessary to increase hospital safety procedures to prevent virus transmissibility from HCW to relatives and non-COVID-19 patients during the upcoming waves of contagion.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study / Qualitative research / Randomized controlled trials Country/Region as subject: Mexico Language: English Year: 2022 Document Type: Article Affiliation country: Healthcare10050896

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study / Qualitative research / Randomized controlled trials Country/Region as subject: Mexico Language: English Year: 2022 Document Type: Article Affiliation country: Healthcare10050896